🇰🇷 South Korea Country × Condition
acute myeloid leukemia Clinical Trials in South Korea
Active clinical trials for acute myeloid leukemia with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05189639
Recruiting
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
Enrollment
165 pts
Country
🇰🇷 South Korea
Pfizer
View Trial → NCT07306832 Phase 1
Recruiting
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
18 pts
Country
🇰🇷 South Korea
AbbVie
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in South Korea?
There are currently 2 active clinical trials for acute myeloid leukemia with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in South Korea?
To join a acute myeloid leukemia clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in South Korea?
Active acute myeloid leukemia trials in South Korea span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology